Berenberg Bank Reaffirms Buy Rating for Assura (LON:AGR)

Berenberg Bank restated their buy rating on shares of Assura (LON:AGR) in a research note issued to investors on Tuesday morning, MarketBeat Ratings reports. They currently have a GBX 51 ($0.67) price objective on the real estate investment trust’s stock.

Separately, Shore Capital reaffirmed a hold rating on shares of Assura in a report on Tuesday, August 13th.

Assura Trading Down 0.7 %

LON:AGR opened at GBX 41.92 ($0.55) on Tuesday. The company has a market capitalization of £1.36 billion, a PE ratio of -4,192.00, a P/E/G ratio of 3.60 and a beta of 0.37. Assura has a 52-week low of GBX 37.54 ($0.50) and a 52-week high of GBX 49.18 ($0.65). The stock’s 50 day moving average price is GBX 41.57 and its 200 day moving average price is GBX 41.39. The company has a quick ratio of 2.84, a current ratio of 0.89 and a debt-to-equity ratio of 85.04.

Assura Announces Dividend

The company also recently declared a dividend, which will be paid on Wednesday, October 9th. Stockholders of record on Thursday, September 5th will be paid a dividend of GBX 0.84 ($0.01) per share. The ex-dividend date is Thursday, September 5th. This represents a dividend yield of 2.01%. Assura’s dividend payout ratio (DPR) is -30,000.00%.

Insider Buying and Selling at Assura

In other news, insider Jonathan Murphy sold 223,534 shares of the stock in a transaction that occurred on Wednesday, July 10th. The stock was sold at an average price of GBX 42 ($0.55), for a total transaction of £93,884.28 ($124,021.51). 8.38% of the stock is owned by corporate insiders.

About Assura

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK – caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.